Long-term Therapeutic Impact of the Timing of Antiretroviral Therapy in Patients Diagnosed With Primary Human Immunodeficiency Virus Type 1 Infection-Reference-Cited by-同舟云学术

Long-term Therapeutic Impact of the Timing of Antiretroviral Therapy in Patients Diagnosed With Primary Human Immunodeficiency Virus Type 1 Infection

Published:2017-12-02 Issue:10 Volume:66 Page:1519-1527
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Novelli Sophie¹,Lécuroux Camille²,Avettand-Fenoel Véronique³,Seng Rémonie⁴,Essat Asma¹,Morlat Philippe⁵,Viard Jean-Paul⁶,Rouzioux Christine³,Meyer Laurence⁴,Goujard Cécile⁷

Affiliation:

1. National Institute of Health and Medical Research (INSERM), Centre for Research in Epidemiology and Population Health (CESP), Paris-Sud University, France

2. Commissariat à l'énergie atomique et aux énergies alternatives (CEA) –Université Paris Sud 11-INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases (IMVA), Infectious Disease Models and Innovative Therapie (IDMIT), Institut de biologie François Jacob (IBJF), Direction de la recherche fondamentale (DRF), Fontenay-aux-Roses, France

3. Paris Descartes University, EA 7327, Sorbonne Paris Cité, Assistance Publique–Hôpitaux de Paris (AP-HP), Necker Hospital, Virology Department, France

4. INSERM, CESP, U1018, Paris-Sud University, AP-HP, Bicêtre Hospital, Department of Public Health and Epidemiology, Le Kremlin-Bicêtre, France

5. Bordeaux University Hospital, Saint André Hospital, Department of Internal Medicine, France

6. Paris Descartes University, EA 7327, Sorbonne Paris Cité, AP-HP, Hôtel Dieu Hospital, Unit of Therapeutics in Immunology and Infectiology, France

7. INSERM, CESP, U1018, Paris-Sud University, AP-HP, Bicêtre Hospital, Department of Internal Medicine, Le Kremlin-Bicêtre, France

Funder

French National Agency for Research on AIDS and Viral Hepatitis

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/66/10/1519/24733456/cix1068.pdf

Reference39 articles.

1. Prevention of HIV-1 infection with early antiretroviral therapy;Cohen;N Engl J Med,2011

2. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts;Hocqueloux;J Antimicrob Chemother,2013

3. Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission;Chéret;J Antimicrob Chemother,2015

4. Short-course antiretroviral therapy in primary HIV infection;SPARTAC Trial Investigators;N Engl J Med,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-AIDS-Defining Events in Human Immunodeficiency Virus Controllers Versus Antiretroviral Therapy–Controlled Patients: A Cohort Collaboration From the French National Agency for Research on AIDS CO21 (CODEX) and CO06 (PRIMO) Cohorts;Open Forum Infectious Diseases;2023-02-01

2. Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers;Nature Communications;2022-04-11

3. Immune Activation in Primary Human Immunodeficiency Virus: Influence of Duration of Infection, Treatment, and Substance Use;Open Forum Infectious Diseases;2022-03-24

4. Primary Care of the Person Living with HIV;Pathogens;2022-03-22

5. Virologic failure in people living with HIV in 1st line ART: A 10-year Mexican population-based study;International Journal of STD & AIDS;2022-02-04